Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NTTG who wrote (12207)	7/9/2013 5:05:41 PM
From: Howard Williams	Read Replies (1) \| Respond to of 13111

>>I have stated before that I am quite interested in seeing the Moffitt MOA data...and have been looking for this since 2010.<< Thank you NTTG. You are not alone re 2010. In a Knoxville News article dated August 18, 2010 .... knoxnews.com ...... this quote appears: "If we had an ironclad explanation of this bystander effect that they could understand that it was … real and … why it was occurring, they would be more amenable to a more aggressive pathway to approval,” Wachter said of the FDA.

To: NTTG who wrote (12207)	7/9/2013 5:58:09 PM
From: Mimbari	Read Replies (1) \| Respond to of 13111

I would imagine that a placebo would be unethical (or should be) and idiotic in cancer patients. Headache patients would be fine with a placebo in the study but not cancer patients. Sorry Mr. Smith but you got red dye number 2 and not PV-10 in the study, your going to die. No, I think the crew at Moffitt are a bit more educated than our one unqualified naysayer. I think they know what they are doing. BTW who is the pogeu mahone character? He keeps bombing my inbox with crazy weird texts. NTTG you have one fan, lol. Pogue Mahone means "kiss my arse" in Irish. He can't even spell that right. I'm thinking he is a third world, goat herding, research assistant to NTTG.